EpiVax is hosting its 5th Annual Immunogenicity and Tolerance Seminar. Our event is scheduled for Friday, November 15, at the Hilton Amsterdam in the Netherlands.
Featured keynote speakers are to include:
Dr. Annie De Groot
Professor (Research) and Director, Institute for Immunology and Informatics (iCubed)
“Setting the Stage: Immunogenicity and Tolerance“
Prof. Dr. Andrew Godkin
Institute of Infection and Immunity
School of Medicine, Cardiff University
“Treg Response in Human Tumors”
Dr. Celia Berkers
Professor of Metabolomics, Utrecht University
“Unraveling the Mechanism of Proteasomal Peptide Splicing“
Dr. Adrian Shepherd
Reader in Computational Biology, Birkbeck, University of London
“Assessing the Risk of Alloimmune Responses by Scanning the Human Proteome“
Dr. Peter de Haan
CSO and Co-founder, Amarna Therapeutics
Annieck Diks, M.Sc.
Doctoral Candidate, Leiden University Medical Center
“B cell Kinetics Following Vaccination“
INTERESTED IN ATTENDING OUR SEMINAR?
* Register here! *
Students = €20 | Non-students = €75
INTERESTED IN SPEAKING AT OUR SEMINAR?
* We have speaking slots available! E-mail firstname.lastname@example.org your proposed topic and abstract *
In the meantime, we encourage you to browse through our previous Immunogenicity and Tolerance Seminars: